Show simple item record

dc.contributor.authorHolladay, Carolyn A.en
dc.contributor.authorO'Brien, Timothyen
dc.contributor.authorPandit, Abhayen
dc.identifier.citationHolladay, C. A., O'Brien, T., & Pandit, A. Non-viral gene therapy for myocardial engineering. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2(3), 232-248.en
dc.description.abstractDespite significant advances in surgical and pharmacological techniques, myocardial infarction (MI) remains the main cause of morbidity in the developed world because no remedy has been found for the regeneration of infarcted myocardium. Once the blood supply to the area in question is interrupted, the inflammatory cascade, among other mechanisms, results in the damaged tissue becoming a scar. The goals of cardiac gene therapy are essentially to minimize damage, to promote regeneration, or some combination thereof. While the vector is, in theory, less important than the gene being delivered, the choice of vector can have a significant impact. Viral therapies can have very high transfection efficiencies, but disadvantages include immunogenicity, retroviral-mediated insertional mutagenesis, and the expense and difficulty of manufacture. For these reasons, researchers have focused on non-viral gene therapy as an alternative. In this review, naked plasmid delivery, or the delivery of complexed plasmids, and cell-mediated gene delivery to the myocardium will be reviewed. Pre-clinical and clinical trials in the cardiac tissue will form the core of the discussion. While unmodified stem cells are sometimes considered therapeutic vectors on the basis of paracrine mechanisms of action basic understanding is limited. Thus, only genetically modified cells will be discussed as cell-mediated gene therapy. Copyright © 2009 John Wiley & Sons, Inc.en
dc.publisherJohn Wiley & Sons, Ltd.en
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland
dc.subjectGene therapyen
dc.subjectMyocardial infarctionen
dc.subjectCell-based therapyen
dc.subjectNetwork of Excellence for Functional Biomaterialsen
dc.titleNon-viral gene therapy for myocardial engineeringen
dc.contributor.funderScience Foundation Irelanden

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland